-
Something wrong with this record ?
The role of UDP-glycosyltransferases in xenobioticresistance
D. Dimunová, P. Matoušková, R. Podlipná, I. Boušová, L. Skálová
Language English Country England, Great Britain
Document type Journal Article, Review, Research Support, Non-U.S. Gov't
- MeSH
- Phylogeny MeSH
- Glycosyltransferases * chemistry genetics metabolism MeSH
- Drug Resistance * MeSH
- Humans MeSH
- Drug Tolerance * MeSH
- Uridine Diphosphate * classification genetics metabolism MeSH
- Xenobiotics * metabolism toxicity MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Uridine diphosphate sugar-utilizing glycosyltransferases (UGTs) are an enzyme superfamily that catalyzes glycosyl residues transfer from activated nucleotide sugars to acceptor molecules. In addition to various endogenous compounds, numerous xenobiotics are substrates of UGTs. As the glycosides formed are generally less active/toxic and more hydrophilic than aglycones, UGTs effectively protect organisms from potentially harmful xenobiotics. Therefore, increased UGT expression and/or activity improve the protection of the organism and may contribute to the development of individuals that become more resistant to certain xenobiotics. While the function of UGTs in the resistance of human cancer cells to chemotherapy is now well known, other organisms and other xenobiotics have attracted much less attention. This review was designed to fill this knowledge gap by presenting complex information about the role of UGTs in xenobiotic-resistance in various organisms. This summarization and evaluation of the available information reveals that UGTs play an important role in defense against xenobiotics not only in humans, but in countless other organisms such as parasites, insects, and plants. Moreover, many recent studies clearly show the participation of UGTs in the resistance of nematodes to anthelmintics, insects to insecticides, weeds to herbicides as well as humans to various drugs (not only those used in cancer therapy but also in the treatment of epilepsy, psychiatric disorders, hypertension, hypercholesterolemia, and HIV infection). Nevertheless, although the contribution of UGTs to xenobiotic resistance in diverse organisms has become obvious, many pieces of information remain missing, for example with regard to the mechanisms of UGT regulation.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22024999
- 003
- CZ-PrNML
- 005
- 20221031100209.0
- 007
- ta
- 008
- 221017s2022 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/03602532.2022.2083632 $2 doi
- 035 __
- $a (PubMed)35635097
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Dimunová, Diana $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
- 245 14
- $a The role of UDP-glycosyltransferases in xenobioticresistance / $c D. Dimunová, P. Matoušková, R. Podlipná, I. Boušová, L. Skálová
- 520 9_
- $a Uridine diphosphate sugar-utilizing glycosyltransferases (UGTs) are an enzyme superfamily that catalyzes glycosyl residues transfer from activated nucleotide sugars to acceptor molecules. In addition to various endogenous compounds, numerous xenobiotics are substrates of UGTs. As the glycosides formed are generally less active/toxic and more hydrophilic than aglycones, UGTs effectively protect organisms from potentially harmful xenobiotics. Therefore, increased UGT expression and/or activity improve the protection of the organism and may contribute to the development of individuals that become more resistant to certain xenobiotics. While the function of UGTs in the resistance of human cancer cells to chemotherapy is now well known, other organisms and other xenobiotics have attracted much less attention. This review was designed to fill this knowledge gap by presenting complex information about the role of UGTs in xenobiotic-resistance in various organisms. This summarization and evaluation of the available information reveals that UGTs play an important role in defense against xenobiotics not only in humans, but in countless other organisms such as parasites, insects, and plants. Moreover, many recent studies clearly show the participation of UGTs in the resistance of nematodes to anthelmintics, insects to insecticides, weeds to herbicides as well as humans to various drugs (not only those used in cancer therapy but also in the treatment of epilepsy, psychiatric disorders, hypertension, hypercholesterolemia, and HIV infection). Nevertheless, although the contribution of UGTs to xenobiotic resistance in diverse organisms has become obvious, many pieces of information remain missing, for example with regard to the mechanisms of UGT regulation.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a léková rezistence $7 D004351
- 650 12
- $a tolerance léku $7 D004361
- 650 12
- $a glykosyltransferasy $x chemie $x genetika $x metabolismus $7 D016695
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a fylogeneze $7 D010802
- 650 12
- $a uridindifosfát $x klasifikace $x genetika $x metabolismus $7 D014530
- 650 12
- $a xenobiotika $x metabolismus $x toxicita $7 D015262
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Matoušková, Petra $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
- 700 1_
- $a Podlipná, Radka $u Laboratory of Plant Biotechnologies, Institute of Experimental Botany, Czech Academy of Sciences, Praha, Czech Republic
- 700 1_
- $a Boušová, Iva $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
- 700 1_
- $a Skálová, Lenka $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
- 773 0_
- $w MED00001447 $t Drug metabolism reviews $x 1097-9883 $g Roč. 54, č. 3 (2022), s. 282-298
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35635097 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20221017 $b ABA008
- 991 __
- $a 20221031100207 $b ABA008
- 999 __
- $a ok $b bmc $g 1854613 $s 1176289
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 54 $c 3 $d 282-298 $e 20220612 $i 1097-9883 $m Drug metabolism reviews $n Drug Metab Rev $x MED00001447
- LZP __
- $a Pubmed-20221017